1. Home
  2. UVE vs DBVT Comparison

UVE vs DBVT Comparison

Compare UVE & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UNIVERSAL INSURANCE HOLDINGS INC

UVE

UNIVERSAL INSURANCE HOLDINGS INC

HOLD

Current Price

$37.94

Market Cap

957.6M

Sector

Finance

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$15.67

Market Cap

948.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVE
DBVT
Founded
1990
2002
Country
United States
France
Employees
N/A
90
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
957.6M
948.8M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
UVE
DBVT
Price
$37.94
$15.67
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$40.00
$32.04
AVG Volume (30 Days)
127.0K
272.5K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
1.97%
N/A
EPS Growth
214.43
10.26
EPS
1.88
N/A
Revenue
$1,603,915,000.00
$5,636,000.00
Revenue This Year
N/A
$35.04
Revenue Next Year
$2.88
$2,360.78
P/E Ratio
$20.21
N/A
Revenue Growth
5.48
35.77
52 Week Low
$21.96
$8.50
52 Week High
$41.96
$26.19

Technical Indicators

Market Signals
Indicator
UVE
DBVT
Relative Strength Index (RSI) 53.27 33.66
Support Level $30.42 $12.63
Resistance Level $38.62 $17.42
Average True Range (ATR) 0.96 0.98
MACD 0.08 -0.05
Stochastic Oscillator 83.90 3.63

Price Performance

Historical Comparison
UVE
DBVT

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: